News
20h
MedPage Today on MSNADA Roundup: Weight-Loss Studies Take Center StageResearch presented at the American Diabetes Association (ADA) annual meeting included a small phase I/II study on stem cell ...
Deepseek AI’s scare kicked off the year, rattling faith in the “Magnificent Seven” and the broader tech space. 💵💰Don't miss ...
13h
The Scarborough News on MSNWeight loss drug 'not available from local GP surgeries or pharmacies'Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...
9h
India Today on MSNWeight-loss and new-age drugs: Dr Ambrish Mithal on Wegovy's India debutWith the weight-loss blockbuster drug Wegovy, now in India, renowned endocrinologist and diabetologist Dr. Ambrish Mithal ...
WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide – the active ...
Boots Online Doctor has revealed the 'very common' side-effects of Mounjaro you need to know about after thousands of people ...
Novo Nordisk launches Wegovy in India, expanding GLP-1 obesity drug market. The product competes with Eli Lilly's Mounjaro ...
Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...
Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...
FAT jabs are shrinking supermarket sales, with grocery volumes falling 0.4% year-on-year, new figures reveal. Popular Ozempic ...
The growing popularity of weight loss jabs could be affecting shopping habits in UK supermarkets, a leading research group ...
Novo Nordisk is banking on its pen-filled device and insulin leadership in India to gain a strong market share despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results